1. Home
  2. Live Updates
  3. Iomarker

Live Breaking News & Updates on Iomarker

Stay informed with the latest breaking news from Iomarker on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Iomarker and stay connected to the pulse of your community

The association between handgrip strength and functional outcomes in long COVID-19

The association between dynapenia with long coronavirus disease 2019 (COVID-19).

Brazil , Ralf-liebhold-shutterstock , Scientific-reports , Coronavirus-disease-covid-19 , Ovid-19 , Iomarker , Oronavirus , Atigue , Ospital , Uscle , Ublic-health

Mood boosters reduce inflammation in IBD by 18%, study finds

New King's College London research reveals that interventions which improve mood can reduce levels of inflammation in people with inflammatory bowel disease by 18 per cent, compared to having no mood intervention.

United-kingdom , London , City-of , King-io , Rona-moss-morris , Valeria-mondelli , Natasha-seaton , National-institute-for-health , King-college-london , Research-council , Psychology-neuroscience-at-king-college-london , Institute-of-psychiatry

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

Florida , United-states , Orlando , Kim-kelderman , Megan-craig , Bio-techne-corporation , Linkedin , Facebook , From-bio-technejan , Techne-corporation , Advanced-cell-diagnostics , Chief-operating

What are the capabilities of a commercially available p-tau217 immunoassay to identify Alzheimer disease pathophysiology?

Researchers determined the utility of a novel and commercially available immunoassay for plasma phosphorylated tau 217 to detect Alzheimer's Disease pathology and evaluate reference ranges for abnormal amyloid β and longitudinal change across three selected cohorts.

Wisconsin , United-states , Roche-neurotoolkit , Sant-pau-initiative-on-neurodegeneration , Translational-biomarkers , Wisconsin-registry , Sant-pau-initiative , Immunoassay , Athophysiology , Lzheimer-39s-disease , Iomarker , Lood

Lung cancer prediction using biomarkers based on bronchoalveolar fluid microbiomes

The lung microbiomes of patients with benign and malignant pulmonary diseases.

Firmicutes-bacteroidetes , Sewcreamstudio-shutterstock , Chungnam-national-university-hospital , Scientific-reports , Cancer , Ung-cancer , Ntigen , Iomarker , Iopsy , Lood , Ronchiectasis , Ronchoscopy

PlaqueTec and Babraham Institute collaborate on phenotypic screen of coronary artery blood

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), and the Flow Cytometry Facility at the Babraham Institute have announced a collaboration to develop a bespoke cell phenotyping assay for human blood.

Rachael-walker , Diane-proudfoot , Babraham-institute , Babraham-research-campus , Flow-cytometry-facility , Markets-amp-regulations , Io-developments , Ipelines , Merging-markets , Lood , Iomarker , Ell

Thinning brain tissue predicts dementia up to a decade before symptoms

A ribbon of brain tissue called cortical gray matter grows thinner in people who go on to develop dementia, and this appears to be an accurate biomarker of the disease five to 10 years before symptoms appear, researchers from The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) reported.

Texas , United-states , Boston-university , Massachusetts , Framingham , San-antonio , California , Claudia-satizabal , Sudha-seshadri , Journal-of-the-alzheimer-association , Glenn-biggs-institute , Ut-health-san-antonio

Novel blood test shows promise in detecting early-stage cancers with high accuracy

Researchers develop a novel plasma proteome-based test for early detection of multiple cancers, achieving high accuracy in identifying low-abundance protein biomarkers.

Neha-mathur , Artemisdiana-shutterstock , Sophia-coveney , Neha-mathurjan , Cancer , Roteome , Ntigen , Ssay , Iomarker , Iopsy , Lood

Study reveals hundreds of genetic markers for insulin resistance

A genome-wide study of 402,398 individuals identifies 369 SNPs associated with insulin resistance, offering insights into metabolic diseases and potential therapeutic targets.

Michigan , United-states , Victor-moussa , Wide-association-study , Traits-consortium , Michigan-genomics-initiative , Nature-genetics , United-kingdom-biobank , United-kingdom , Image-credit , Insulin-resistance , Genetic-investigation

Research reveals COVID-19's lasting impact on brain function and structure

Study investigates post-COVID-19 cognitive defects, finding that SARS-CoV-2 infections are linked to brain injury markers and reduced cingulate cortex volume, with corticosteroids offering some cognitive protection.

United-kingdom , National-institute-of-health-research , Research-square , Neuroscience-study , National-institute , Health-research , Complex-attention , Perceptual-motor-control , Brain , Oronavirus-disease-covid-19 , Esearch